Resistin levels in morbid obese patients following the biliopancreatic diversion surgery

Hormone and Metabolic Research

Volumn 43, Issue 3, 2011, Pages 205-208

  De Luis, D A ^a   Terroba, M C ^a   Cuellar, L ^a   Conde, R ^a   Primo, D ^a   Aller, R ^a   Sagrado, M G ^a   Izaola, O ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

biliopancreatic diversion; morbid obesity; resistin; surgery

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BILIOPANCREATIC BYPASS; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; BILIOPANCREATIC DIVERSION; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; RESISTIN; WEIGHT LOSS;

EID: 79952487719     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1270529     Document Type: Article

References (25)

1. Aranceta J, Perez Rodrigo C, Serra Majem L. Prevalencia de la obesidad en Espaa: estudio SEEDO 97. Med Clin (Barc) 1998 111 441-445 (Pubitemid 128524823)
2. de luis DA, Aller R, Izaola O, Pacheco D. Early clinical and surgical results of biliopancreatic diversion. Obes Surg 2005 15 799-802 (Pubitemid 40904869)
3. Scopinaro N, Adami GF, Marinari GM. Biliopancreatic diversion. World J Surg 1998 22 936-946 (Pubitemid 28374611)
4. Matsuda M, Shimomura I, Sata M. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002 277 37487-37491
5. Steppan CM, Bailey ST, Bhat S, Brown EJ. The hormone resistin links obesity to diabetes. Nature 2001 409 307-312 (Pubitemid 32151228)
6. Satoh H, Nguyen MT, Miles PD, Immamura T, Usui I, Olefsky JM. Adenovirus-mediated chronic hyper resistinemia leads to in vivo insulin resistance in normal rats. J Clin Inves 2004 114 224-231 (Pubitemid 39071627)
7. Steppan CM, Lazar MA. The current biology of resistin. J Intern Med 2004 255 439-447 (Pubitemid 38446357)
8. Sato N, Kobayashi K, Inoguchi T, Sonoda N, Immamura M, Sekiguchi N, Nakashima N, Nawata H. Adenovirus-mediated high expression of resistin causes dyslipemia in mice. Endocrinol 2005 146 273-279 (Pubitemid 40051749)
9. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, Scherr PE, Rossetti L. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 2004 114 232-239 (Pubitemid 39071628)
10. Patel L, Buckles AC, Kinghorn IJ, Murdock PR, Holbrook JD. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activated receptor gamma action in humans. Biochem Biophys Res Commun 2003 300 472-476 (Pubitemid 38375833)
11. Pagano C, Marin O, Calcagno A, Schiappelli P, Pilon C, Milan G, Bertelli M, Fanin E. Increased serum resistin in adults with Prader Willi syndrome is related to obesity and not to insulin resistance. J Clin Endocrinol Metab 2005 90 4335-4340 (Pubitemid 41058216)
12. Burnett MS, Devaney JM, Adenika RJ, Lindsay R, Howard BV. Cross-sectional associations of resistin, coronary heart disease and insulin resistance. J Clin Endocr Metab 2006 91 64-68 (Pubitemid 43069119)
13. De Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O. Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients. Diab Res Clin Res 2009 84 174-178
14. Zou CC, Liang L, Hong F, Fu JF, Zhao ZY. Serum adiponectin, resistin levels and non alcoholic fatty liver disease in obese children. Endocrine J 2005 52 519-524 (Pubitemid 41609038)
15. Moschen AR, Molnar C, Wolf A, Weiss H, Graziadei I, Kaser S, Ebenbichler CF, Stadlmann S, Moser P, Till H. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. J Hepatol 2009 51 765-777
16. Whitson B, Leslie D, Kellog T, Maddaus M, Buchwald H, Billington C, Ikramuddin S. Adipokine response in diabetics and nondiabetes following the roux en y gastric bypass: a preliminary study. Journal of Surgery Research 2007 142 295-300 (Pubitemid 47418830)
17. Argentou M, Tiniakos DG, Karanikolas M, Melachrinou M, Makri MG, Kittas C, Kalfarentzos F. Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery. Obes Surg 2009 19 1313-1323
18. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 285 2486-2487
19. Standards of diabetes mellitus, American Diabetes Association. Diabetes Care 2007 30 s4-s41
20. Pfutzner A, Langenfeld M, Kunt T, Lobig M, Forst T. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab 2003 49 571-576 (Pubitemid 37493455)
21. Iqbal N, Seshadri P, Stern L, Loh J, Kundu S, Jafar T, Samaha FE. Serum resistin is not associated with obesity or insulin resistance in humans. European Rev Med Pharmacol Sci 2005 9 161-165 (Pubitemid 40975765)
22. Vendrell J, Broch M, Vilarrasa N. Resistin, adiponectin, ghrelin, leptin and proinflammatory cytokines: relationships in obesity. Obes Res 2004 12 962
23. Santoro S, Malzoni CE, Velhote MC, Milleo FQ, Santo MA, Klajner S, Daminai D. Digestive adaptation with intestinal reserve: a neuroendocrine based operation for morbid obesity. Obes Surg 2006 16 1371-1379 (Pubitemid 44671812)
24. Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial. Hepatology 2009 49 80-86
25. Busetto L, BAsseto F, Zocchi M, Zuliani F, Nolli ML, Pigozzo S, Coin A, Mazza M, Sergi G, Mazzoleni F. The effects of the surgical removal of subcutaneous adipose tissue on energy expenditure and adipocytokine concentrations in obese women. Nutr Metab Cardiovasc Dis 2008 18 112-120 (Pubitemid 351282468)